Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Open Access Guideline
Open Access Guideline
Postgraduate Thesis Guideline
Postgraduate Thesis Guideline
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
Analyzing the expression patterns of vitamin D metabolizing CYP27B1 and CYP24A1 in brain tissue of vitamin D treated mice with Multiple Sclerosis (MS)
Download
10488504.pdf
Date
2022-8
Author
Özdoğan, Dilara
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
271
views
136
downloads
Cite This
The etiopathogenesis of Multiple Sclerosis (MS), an inflammatory demyelinating autoimmune disease of the central nervous system, is still unknown. MS is a complex, recurring, and frequently progressing condition. There is a hypothesis that MS is adversely associated with the length and intensity of sunlight exposure and vitamin D concentrations since MS frequency rises with increasing latitude. A female C57BL/6 mouse model for autoimmune encephalomyelitis (EAE) was used in this investigation to examine the associations between vitamin D supplementation, MS, and the vitamin D metabolizing CYP enzymes CYP27B1, and CYP24A1 at the protein expression levels. Initially, mice were separated into four groups: Gr 1 (Control), Gr 2 (Vitamin D supplemented control), Gr 3 (EAE – MS Model), and Gr 4 (vitamin D supplemented EAE – MS Model). The protein expression levels of Gr 1 were adjusted to 1.00 fold, and expression levels of the other groups were determined relative to Gr 1. No statistically significant difference was observed in mice brain CYP27B1 and CYP24A1 protein expressions among the groups. However, there was a slight decrease in the mice brain CYP24A1 protein expressions of vitamin D supplemented groups (Gr 2 and Gr 4) compared to their control groups (Gr 1 and Gr 3). In conclusion, in the future both CYP24A1 inhibitor therapy and vitamin D supplementation might be tested out to assist reducing the intensity of MS symptoms.
Subject Keywords
Vitamin D
,
Multiple Sclerosis (MS)
,
Vitamin D Metabolizing CYPs
,
Experimental Autoimmune Encephalomyelitis (EAE)
,
Brain
URI
https://hdl.handle.net/11511/98612
Collections
Graduate School of Natural and Applied Sciences, Thesis
Suggestions
OpenMETU
Core
INVESTIGATION OF EFFECTS OF VITAMIN D AND VITAMIN D METABOLIZING CYP450 ISOZYMES ON MULTIPLE SCLEROSIS PATHOPHYSIOLOGY IN ANIMAL MODEL BY MOLECULAR APPROACHES
Evin, Emre; Adalı, Orhan; Department of Biology (2021-8)
Multiple sclerosis (MS) is a complicated, recurrent, and often progressive inflammatory demyelinating autoimmune disease of the central nervous system, yet etiopathogenesis remains unsolved. MS frequency increases with increasing latitude, leading to a hypothesis that MS is inversely correlated with the duration and intensity of sunlight and vitamin D concentrations. In this study, the relationships between vitamin D supplementation, MS, VDR, and vitamin D metabolizing CYP enzymes, including CYP2R1, CYP27A1...
Investigation of Glutathione S-Transferase (GST) expression and activity in mouse with Multiple Sclerosis (MS)
Arçak, Deniz; Adalı, Orhan; Evin, Emre; Department of Biology (2022-5-11)
Multiple Sclerosis (MS) of unknown etiopathogenesis is a chronic demyelinating disease of the central nervous system. It mainly destroys myelin in the brain and spinal cord. Non-traumatic injuries have been observed in this disease for young adults. Various factors affect MS, but oxidative stress is one of the most important causes of demyelination. Glutathione S- Transferases (GSTs) can be described as a versatile enzyme family of eukaryotic and prokaryotic phase II metabolic isoenzymes. They have enzymati...
INVESTIGATION OF INFLAMMATION ASSOCIATED CYP2E1 AND CYP1A1 EXPRESSION IN THE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS MOUSE MODEL OF MULTIPLE SCLEROSIS
Solak, Damla; Adalı, Orhan; Department of Molecular Biology and Genetics (2023-1-27)
Multiple sclerosis (MS) is an autoimmune neurodegenerative disease which affects brain and spinal cord. Myelin which wraps around the axon and its progenitor cells, oligodendrocytes, are destroyed in this disease. This results in the loss of signal transmission which leads to axonal, and eventually neuronal loss. There are various symptoms of the disease such as unstable feelings, fatigue, visual disability, muscle spasms, and walking difficulties. The etiology of the disease is still in its infancy; howeve...
Generation and Characterization of Induced Pluripotent Stem Cell Lines From Multiple Sclerosis Patients and Healthy Individuals
Begentaş, Onur Can; Kiriş, Erkan; Department of Molecular Biology and Genetics (2021-9-8)
Multiple Sclerosis (MS) is an autoimmune disease characterized by inflammation, demyelination, and axonal damage resulting in neurodegeneration in the central nervous system (CNS). Relapsing-remitting MS (RRMS) is the most common form of the disease known to affect more than 2 million individuals globally, and the prevalence of the disease is increasing worldwide. As a chronic condition without a cure, RRMS manifests in a relapsing-remitting form with sporadic attacks suddenly appearing, causing neurologica...
ASSOCIATION OF THE VITAMIN D METABOLIZING CYP24A1, CYP27A1, CYP27B1 AND VITAMIN D RECEPTOR GENETIC POLYMORPHISMS WITH MULTIPLE SCLEROSIS RISK IN TURKISH POPULATION
Bulut, Giray; Adalı, Orhan; Demirkaya, Şeref; Department of Biochemistry (2023-1-25)
Multiple Sclerosis (MS) is the most common nontraumatic cause of young disability. There are many studies indicating the relationship between MS and vitamin D. Activation of vitamin D requires a series of hydroxylations that are conducted by cytochrome P450 enzymes (CYPs). Vitamin D shows its effects by binding to vitamin D receptor (VDR). In the present study, vitamin D metabolism related mitochondrial CYPs (CYP27A1, CYP27B1 and CYP24A1) and VDR gene polymorphisms were selected for investigation. 187 (130 ...
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
D. Özdoğan, “Analyzing the expression patterns of vitamin D metabolizing CYP27B1 and CYP24A1 in brain tissue of vitamin D treated mice with Multiple Sclerosis (MS),” M.S. - Master of Science, Middle East Technical University, 2022.